Immune to Cancer: The CRI Blog
-
CRI Funded Scientist
Jiayu Ye, PhD
Ovarian cancer remains one of the deadliest cancers for women, in part because many tumors are “immune… -
CRI Funded Scientist
Jingya Qiu, PhD
Many cancers develop slowly over years, passing through pre-malignant stages where early immune responses may determine whether… -
CRI Funded Scientist
Baolin Liu, PhD
Immune checkpoint blockade (ICB) has transformed cancer treatment, yet many patients still fail to respond, and the… -
CRI Funded Scientist
Sui Yuk Chan, PhD
Glioblastoma is the most aggressive and deadly form of brain cancer, yet it is usually discovered only… -
CRI Funded Scientist
José Almeida Santos, PhD
Most successful cancer treatments rely on the ability of T cells to recognize and destroy tumor cells,… -
CRI Funded Scientist
Yebin Wang, PhD
The immune system must strike a delicate balance: protecting the body from infection and cancer while avoiding… -
CRI Funded Scientist
Hejia Wang, MD, PhD
Colorectal cancer is the second leading cause of cancer deaths in the United States, and for patients… -
CRI Funded Scientist
Hao Wang, PhD
Immune checkpoint therapies have revolutionized cancer treatment by reawakening the body’s immune system to attack tumors. Yet,… -
CRI Funded Scientist
Lion Uhl, DPhil
The immune system must constantly balance attack and restraint—fighting infections and cancer while avoiding the harmful inflammation…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.